Nazara Tech IPO: How to check share allotment status
This was the third highest-ever subscription for an Indian IPO with an issue size of over Rs 200 crore. The previous record was held by MTAR Tech, the Hyderabad-based precision engineering solutions company, whose issue had been subscribed more th...
By ETMarkets.com | Updated:
iStock
HNIs emerged the biggest bidders for the Nazara IPO with 390 times subscriptions, while the retail quota got subscribed 75 times. The quota for qualified institutional bidders (QIB) was subscribed 104 times.
NEW DELHI: Rakesh Jhunjhunwala-backed mobile gaming leader Nazara Technologies, whose Rs 583 crore initial public offer (IPO) was sold between March 17 and 19, will finalise share allotment on Wednesday.
The issue, which was sold in the Rs 1,100-1,101 price band, received stellar response with 176 times subscription.
This was the third highest-ever subscription for an Indian IPO with an issue size of over Rs 200 crore. The previous record was held by MTAR Technologies, the Hyderabad-based precision engineering solutions company, whose issue had been subscribed more than 200 times last month.
Mrs Bectors Food Specialities' IPO last year was subscribed 199 times. Some of the other IPOs of 2020 like Mazagon Dock, Burger King, Happiest Minds and Chemcon Speciality Chemicals were subscribed more than 150 times.
HNIs emerged the biggest bidders for the Nazara IPO with 390 times subscriptions, while the retail quota got subscribed 75 times. The quota for qualified institutional bidders (QIB) was subscribed 104 times.
Nazara is the only company in India to have rights over IP and assets across grassroot, regional, national and international eSports. The company has market-first positions in India across sports simulation and eSports. Its eSports content business grew 60 per cent in FY20 and nine times in last three years.
ADVERTISEMENT
Choice Broking is expecting Nazara's topline to rise 33.8 per cent annually to Rs 593 crore by FY23, based on conservative estimates. It expects Ebitda to expand 11 percentage points to 8.8 per cent (from -2.2 per cent in FY20) and PAT margin to grow 3 percentage points to 2.6 per cent (also negative in FY20) in FY23.
Investors, who have bid for the issue, can check the share allotment status on the following channels:
You can also check the share allotment status on the online portal of Link Intime India Private Ltd, the registrar to the issue. A registrar is a Sebi-registered entity, qualified to act as such and which electronically processes all applications, and carries out the allotment process as per the prospectus.
10 stocks that analysts recommend for handsome returns in the near term
1/11
Amid uncertainties on Dalal Street triggered by rising bond yields and increasing Covid-19 cases, the focus will remain on stock-specific action. Here are a few stocks that analysts say can help investors earn significant returns in the next few weeks:
Amid uncertainties on Dalal Street triggered by rising bond yields and increasing Covid-19 cases, the focus will remain on stock-specific action. Here are a few stocks that analysts say can help inve..
Read More
The stock has corrected more than 8 per cent from its all-time high registered last week. Currently, it is trading near its 20-day simple moving average, trading near an important retracement level on the weekly chart, indicating high chances of a trend reversal in the short term. In addition, on the weekly and monthly charts, the stock has maintained a higher bottom series pattern, which has helped positional traders take a positive stance near the crucial support zone.
(Analyst: Shrikant Chouhan, Executive Vice President, Equity Technical Research at Kotak Securities)
The stock has corrected more than 8 per cent from its all-time high registered last week. Currently, it is trading near its 20-day simple moving average, trading near an important retracement level o..
Read More
The stock is hovering in the range of Rs 320-360 after a sharp correction. However, the medium-term wave structure of Bandhan Bank is still on the positive side. Hence, an ideal strategy should be to add this stock near its support levels. Moreover, it has taken strong support near a 200-day simple moving average along with modest volume activity. A strong bullish candle on the daily chart indicates high chances of a fresh uptrend from current levels.
(Analyst: Shrikant Chouhan, Executive Vice President, Equity Technical Research at Kotak Securities)
The stock is hovering in the range of Rs 320-360 after a sharp correction. However, the medium-term wave structure of Bandhan Bank is still on the positive side. Hence, an ideal strategy should be to..
Read More
The stock has registered a sharp surge in the recent past, but it has failed to sustain higher levels after the Rs 955 breakout and corrected nearly 10 per cent due to consistent selling pressure. However, the medium-term structure of the stock is still on the positive side, and likely to continue in the near term. In addition, on the weekly charts, the stock is still maintaining a higher bottom series formation, which is broadly positive. Currently, the stock is trading near an important retracement support level, and the structure of the charts suggests high chances of a fresh uptrend wave from current levels.
(Analyst: Shrikant Chouhan, Executive Vice President, Equity Technical Research at Kotak Securities)
The stock has registered a sharp surge in the recent past, but it has failed to sustain higher levels after the Rs 955 breakout and corrected nearly 10 per cent due to consistent selling pressure. Ho..
Read More
The stock has broken out on the daily chart with higher volumes, where it closed at an all-time high. Oscillators like RSI and MFI are showing strength, and the directional indicator is placed above the minus side while ADX is placed above 20, indicating momentum in the current uptrend. Technology as a sector is looking good on the chart from the short- to medium-term perspective. Buying is recommended at the CMP of Rs 1,942 for a target of Rs 2,100 with a stop loss at Rs 1,860.
(Analyst: Nandish Shah, Technical Research Analyst, HDFC Securities)
The stock has broken out on the daily chart with higher volumes, where it closed at an all-time high. Oscillators like RSI and MFI are showing strength, and the directional indicator is placed above ..
Read More
The stock has broken out on the daily chart to close at its highest level since April 2019. The short-term trend is positive where it is trading above its five- and 20-day exponendial moving averages. Also, the directional indicator is placed above the minus side while ADX is placed above 20, indicating momentum in the current uptrend. Volumes have been higher on the up days in comparison to down days in the last few weeks, indicating accumulation in the stock. The stock is forming a higher top-higher bottom formation on the daily chart. Buying Godrej Ind is recommended at the CMP of Rs 517 for a target of Rs 570 with a stop loss at Rs 485.
(Analyst: Nandish Shah, Technical Research Analyst, HDFC Securities)
The stock has broken out on the daily chart to close at its highest level since April 2019. The short-term trend is positive where it is trading above its five- and 20-day exponendial moving averages..
Read More
The stock started its recent upmove from the Rs 881.5 mark, and made a high of Rs 1,460 in January 2021. Since then, profit-booking has followed, with the stock making a series of higher bottoms starting at Rs 1,065. The stock recently gave a pattern breakout backed by supportive volumes, and made a high of Rs 1,318, and is trading above all averages that are in a rising trend. Observing the trend, the stock has a potential to test the levels of Rs 1,800, and then Rs 2,000 and Rs 2,200 in the coming days. Any corrections during this period can be used to add the stock, with a stop loss at Rs 1,060.
The stock started its recent upmove from the Rs 881.5 mark, and made a high of Rs 1,460 in January 2021. Since then, profit-booking has followed, with the stock making a series of higher bottoms star..
Read More
The stock started its upmove from the Rs 862 level, which was followed by steady buying to take it to a high of Rs 1,259 in February. A couple of up-gaps were formed in the upmove, suggesting good buying strength, with the 200-day moving average continuously rising since December. The super trend indicator is continuously in a positive mode. Recently, the stock gave a weekly breakout from a range to make a high of Rs 1,415, and is trading above all averages which are are in a rising trend mode. The stock appears to have the potential to test the Rs 1,700 level, followed by Rs 1,900 and then Rs 2,100, in the coming days. Any corrections can be used to add the stock during this period, with a stop loss at Rs 1,100.
The stock started its upmove from the Rs 862 level, which was followed by steady buying to take it to a high of Rs 1,259 in February. A couple of up-gaps were formed in the upmove, suggesting good bu..
Read More
Overall, the entire PSU space has been buzzing for the past three months, within which, the marquee OMC counter has been in a limelight every now and then. On the price front, the stock seems to have a sturdy structure on the weekly chart, and the recent correction appears to have completed on the lower degree chart. The stock managed to find support at the previous multiple resistance zone around Rs 424, which coincides with the 89-day exponential moving average, which indicates that the stock can resume its upward trend. Going long on dips is recommended for a target of Rs 448 in the coming days, with a strict stop loss at Rs 418.
(Analyst: Sameet Chavan-Chief Analyst-Technical and Derivatives, Angel Broking)
Overall, the entire PSU space has been buzzing for the past three months, within which, the marquee OMC counter has been in a limelight every now and then. On the price front, the stock seems to have..
Read More
The pharmaceuticals universe has been quiet for the last couple of months, with many stocks having undergone decent price- and time-wise corrections. The stock saw a correction of nearly 20 per cent from its recent highs, and is seen rebounding precisely after sliding a tad below its 200-day simple moving average on the daily chart. The stock has closed above this key moving average. The candle resembles a bullish hammer pattern, with the possibility of some relief. Going long on the stock is recommended on declines around Rs 418 for a target of Rs 445 in the coming days, with a strict stop loss at Rs 407.
(Analyst: Sameet Chavan-Chief Analyst-Technical and Derivatives, Angel Broking)
The pharmaceuticals universe has been quiet for the last couple of months, with many stocks having undergone decent price- and time-wise corrections. The stock saw a correction of nearly 20 per cent ..
The registrar is responsible for complying with the timelines for updating the electronic credit of shares to successful applicants, dispatch, and uploading of refunds, and attending to all investor-related queries after the issue is completed.
